What does Oncologix Tech Inc. do?

Oncologix Tech Inc. (OCLG) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is OCLG's market cap?

Oncologix Tech Inc. (OCLG) has a market capitalization of approximately $73,662, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does OCLG pay a dividend?

No — Oncologix Tech Inc. (OCLG) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Oncologix Tech Inc. (OCLG) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

OCLG

Oncologix Tech Inc.

OTC·Medical, Diagnostics & Research · Healthcare

$0.00$0.00+0.00%

Market cap$73.66K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−98.84%CAGR −59.00%

Select date range

FromTo

Jan 2, 2013Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

OCLG does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateJul 21

Last Report DateJul 21

Reported vs Estimate−$0.00

Earnings Surprise—

FinancialsFinancials Tab

Revenue$2.16M

Net Income−$1.73M

Net Margin−80.2%

Operating Cash Flow−$18.77K

Capital Expenditures$0.00

Free Cash Flow−$18.77K

Return on Equity—

Return on Invested Capital−387.0%

Net Debt$18.77K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for OCLG and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how OCLG's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OCLG and 80,000+ other tickers.

About Oncologix Tech Inc.

Oncologix Tech, Inc. is a biopharmaceutical company whose main products include DNAGO and genomego which provides clinical genetic testing on all 20,000+ genes encompassing over 7,000 rare genetic diseases. It also previously operated in personal home care services and the manufacturing and distribution of medical technologies. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007.

CEO: Michael A. Kramarz
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: OTC
Employees: 191
Website: www.oclghealth.com

Peers

Peers Tab

CGSI

CGS International, Inc.

Cap

$3.7K

INNX

Infinite Networks Corporation

Latest News

News Tab

No recent news available.

Frequently Asked Questions About OCLG

What does Oncologix Tech Inc. do?: Oncologix Tech Inc. (OCLG) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is OCLG's market cap?: Oncologix Tech Inc. (OCLG) has a market capitalization of approximately $73,662, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does OCLG pay a dividend?: No — Oncologix Tech Inc. (OCLG) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is OCLG profitable?: Oncologix Tech Inc. (OCLG) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.